AI isn't the future—it's now. Meet the Forbes 30 Under 30 revolutionaries harnessing machine learning to build robotic astronauts, cut off funding for terrorists, and turn anyone into a genius coder.This is the new class of innovators making history.See the full 2026 #ForbesUnder30 list: https://t.co/o5fMdPuFMs(Photography by Sebastian Nevols; Additional Photography by Guerin Blask) ...

Core Insights - Predictive Oncology Inc. has regained compliance with Nasdaq's minimum stockholders' equity requirement of $2,500,000, allowing its shares to continue trading on the Nasdaq Capital Market under the ticker "POAI" [1] - The company is focusing on a digital asset strategy centered around the Aethir network's native utility token, ATH, which aims to create a Strategic Compute Reserve [3] Company Overview - Predictive Oncology utilizes AI and machine learning to enhance early drug discovery, particularly for cancer treatment, with its AI platform, PEDAL, achieving a 92% accuracy rate in predicting tumor responses to drug compounds [2] - The company maintains a biobank of over 150,000 assay-capable heterogeneous human tumor samples, providing extensive resources for drug discovery [2] Digital Asset Strategy - The digital asset treasury strategy involves holding ATH tokens, positioning the company as an operator within the Aethir ecosystem, which aims to democratize access to AI infrastructure globally [3]

Core Insights - Predictive Oncology Inc. has regained compliance with Nasdaq's minimum stockholders' equity requirement of $2,500,000, allowing its shares to continue trading on the Nasdaq Capital Market under the ticker "POAI" [1] - The company is focusing on a digital asset strategy centered around the Aethir network's native utility token, ATH, as part of its transformational treasury strategy [1][3] Company Overview - Predictive Oncology utilizes artificial intelligence and machine learning to enhance early drug discovery, particularly for cancer treatment, with a platform called PEDAL that predicts drug response with 92% accuracy [2] - The company has access to a biobank of over 150,000 human tumor samples, providing a comprehensive AI-based drug discovery solution [2] Digital Asset Strategy - The company operates a digital asset treasury focused on the ATH token, aiming to create a Strategic Compute Reserve and enhance the Aethir ecosystem's infrastructure for AI [3]

Core Insights - Apple's head of artificial intelligence and machine learning, John Giannandrea, has stepped down and will be replaced by Amar Subramanya, a former Microsoft AI executive [1][3] - Giannandrea will remain as an advisor until his retirement next spring, and Tim Cook expressed gratitude for his contributions to Apple's AI advancements [3][8] - Apple has been criticized for lagging behind competitors like Google in AI development, particularly with its AI agent Siri, which was once industry-leading [4][7] Leadership Changes - Amar Subramanya, who has two decades of experience in the industry and oversaw the development of Gemini at Google, will take over the AI leadership role at Apple [1][8] - The leadership transition is aimed at accelerating Apple's efforts in delivering intelligent and personalized experiences [8] Competitive Landscape - Apple has adopted a "second-mover advantage" strategy, focusing on refining technologies before release, which has led to slower AI system rollouts compared to competitors [5][7] - The integration of Apple's AI system with applications is not as advanced as that of Android phones powered by Gemini, with some tasks requiring external assistance from ChatGPT [7]

Core Insights - Victory Square Technologies Inc. reported its financial results for Q3 and nine months ended September 30, 2025, highlighting significant developments across its various platforms, including digital health, biotech, pet wellness, climate tech, and immersive technology [1][4]. Financial Highlights - For Q3 2025, the company achieved adjusted revenue of $12.83 million and GAAP revenue of $10.52 million, with a gross margin of $2.33 million and adjusted EBITDA of $1.26 million [8]. - For the nine months ended September 30, 2025, adjusted revenue reached $26.71 million and GAAP revenue was $20.44 million [8]. Portfolio & Strategic Update - Hydreight Technologies, the flagship digital health subsidiary, continued to drive operational performance, recognized as one of the fastest-growing companies in North America [5][6]. - Hydreight's strategic positioning includes a focus on high-growth health segments such as GLP-1 therapies and hormone optimization, supported by a robust compliance infrastructure [10]. - The company launched a $10 million accelerator to incubate direct-to-consumer health companies scaling on the VSDHOne platform [16]. Digital Health Initiatives - Victory Square supports various digital health platforms, including telehealth and diagnostics, aimed at enhancing metabolic health, dermatology, and preventative health [13]. - The digital health market is experiencing increased adoption, with a projected U.S. healthcare spending reaching $7.2 trillion by 2031 [17]. Biotech and Pet Health Platforms - Insu Therapeutics is advancing its oral insulin tablet development, targeting first-in-human studies for 2026 [19][23]. - Pawsible Ventures launched a $10 million fund to accelerate innovation in pet health, aiming to support 15-20 companies over the next three years [19]. Immersive Technology - XR Immersive Tech is expanding into health-related intellectual property, focusing on digital health applications and patient education [20][24]. - Current development areas include digital twin models for chronic-condition tracking and immersive patient engagement tools [21][27]. Additional Notes - Victory Square manages a diversified portfolio of over 20 companies across various sectors, including digital health, AI, and climate tech [26][35]. - The company is actively reviewing monetization opportunities for non-core assets, including a recent Normal Course Issuer Bid allowing the repurchase of up to 5 million common shares [26].

Core Insights - Apple has appointed an outsider to lead its machine-learning research and foundation models efforts [1] Company Developments - The new leader will focus on enhancing Apple's capabilities in machine learning [1] - This move indicates Apple's commitment to advancing its technology in artificial intelligence [1] Industry Implications - The appointment reflects a broader trend in the tech industry where companies are increasingly investing in AI and machine learning [1] - This strategic shift may position Apple to better compete with other tech giants in the AI space [1]

The leaders who succeed in the coming year won't be machine learning experts. They'll be the ones who grasp how AI transforms human work and can guide their teams through that shift with clarity, empathy and humility. Here are five ways AI will transform the role of manager in 2026.Read more: https://t.co/IUlDKo0CKD ...

5 Ways AI Will Transform The Manager Role In 2026The leaders who succeed in the coming year won't be machine learning experts. They'll be the ones who grasp how AI transforms human work and can guide their teams through that shift with clarity, empathy and humility.Here are five ways AI will transform the role of manager in 2026. https://t.co/IUlDKo0CKD ...

Core Insights - Snowflake (SNOW) is expected to report third-quarter fiscal 2026 results on December 3, with earnings estimated at 31 cents per share, reflecting a year-over-year growth of 55% and revenues projected at $1.18 billion, indicating a 25.39% increase from the previous year [1][5]. Group 1: Financial Performance Expectations - The consensus estimate for product revenues in Q3 fiscal 2026 is between $1.125 billion and $1.13 billion, representing a year-over-year growth of 25% to 26% [5][9]. - The Zacks Consensus Estimate for customers with trailing 12-month product revenues greater than $1 million is currently at 686, suggesting a 26.5% increase year-over-year [6]. Group 2: Customer Growth and Retention - Snowflake's net revenue retention rate stands at 125%, with a 19% year-over-year growth in the number of customers, reaching 12,062 [3]. - The company added 533 net new customers in Q2, marking a 21% increase year-over-year [4]. Group 3: AI and Technological Advancements - Snowflake has launched approximately 250 new capabilities in the first half of fiscal 2026, enhancing data management and AI-driven insights [14]. - Nearly 50% of new customer logos in Q2 were influenced by AI, with 25% of deployed use cases involving AI [16]. Group 4: Strategic Partnerships - Snowflake's strong partner base includes major companies like SAP, Microsoft, AWS, and NVIDIA, which has significantly contributed to its growth [18]. - The collaboration with NVIDIA enhances Snowflake's machine learning capabilities, allowing for improved data science workflows [19]. Group 5: Stock Performance and Valuation - Snowflake shares have appreciated 62.7% year-to-date, outperforming the Zacks Computer & Technology sector and the Zacks Internet Software industry [7]. - The stock is currently trading at a forward 12-month Price/Sales ratio of 15.6X, indicating a stretched valuation compared to the industry average of 4.87X [11].

Joining us this morning with some thoughts, Bob Griffeld, managing partner at Cornerstone Financial Technology Management, of course, former CEO of NASDAQ. Bob, good to see you again. Thanks for joining us.>> Glad to be here. >> Sounds like you think this is kind of Nvidia's moving up the stack a little bit. >> Exactly.When you think about him talking about CPUs versus GPUs, we understand that CPUs were commoditized. So basically, I would state that over time hardware consistently has been commoditized. So ...